NEW YORK (GenomeWeb News) — Bruker BioSciences today said it has obtained a non-exclusive worldwide license from Health Discovery Corporation to use its Support Vector Machine (SVM) technology in Bruker Daltonics’ ClinProTools clinical proteomics product line.
ClinProTools is a bioinformatics product for biomarker panel analysis, biofluid profiling, multivariate data analysis, classical statistics, and sample classification.
SVMs are supervised classification algorithms that can analyze high-dimensional mass spectrometric data from a plurality of sample cohorts and “complement” the use of other classification algorithms, such as Bruker’s Supervised Neural Network, its QuickClassifier, modified genetic algorithms, and others,” according to Bruker.
The agreement provides for an up-front fee and royalties based on sales. Financial details were not disclosed.